Chen-Yu Zhang

Dr. Chen-Yu Zhang

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CZChen-Yu Zhang
Chen-Yu Zhang
XTXiao-Hua Tan
Xiao-Hua Tan
HYHui-Hui Yang
Hui-Hui Yang
.J. Jin
. Jin
JHJie-Ru Hong
Jie-Ru Hong
XHXiao-Ting Huang
Xiao-Ting Huang
We previously found that the disorder of soluble epoxide hydrolase (sEH)/cyclooxygenase-2 (COX-2)-mediated arachidonic acid (ARA) metabolism contributes to the pathogenesis of the non-alcoholic fatty liver disease (NAFLD) in mice. However, the exact mechanism has not been elucidated. Accumulating evidence points to the essential role of cellular senescence in NAFLD. Herein, we investigated whether restoring the balance of sEH/COX-2-mediated ARA metabolism attenuated NAFLD via hepatocyte senescence. A promised dual inhibitor of sEH and COX-2, PTUPB, was used in our study to restore the balance of sEH/COX-2-mediated ARA metabolism. In vivo, NAFLD was induced by a high-fat diet (HFD) using C57BL/6J mice. In vitro, mouse hepatocytes (AML12) and mouse hepatic astrocytes (JS1) were used to investigate the effects of PTUPB on palmitic acid (PA)-induced hepatocyte senescence and its mechanism. PTUPB alleviated liver injury, decreased collagen and lipid accumulation, restored glucose tolerance, and reduced hepatic triglyceride levels in HFD-induced NAFLD mice. Importantly, PTUPB significantly reduced the expression of liver senescence-related molecules p16, p53, and p21 in HFD mice. In vitro, the protein levels of γH2AX, p53, p21, COX-2, and sEH were increased in AML12 hepatocytes treated with PA, while Ki67 and PCNA were significantly decreased. PTUPB decreased the lipid content, the number of β-gal positive cells, and the expression of p53, p21, and γH2AX proteins in AML12 cells. Meanwhile, PTUPB reduced the activation of hepatic astrocytes JS1 by slowing the senescence of AML12 cells in a co-culture system. It was further observed that PTUPB enhanced the ratio of autophagy-related protein LC3II/I in AML12 cells, up-regulated the expression of Fundc1 protein, reduced p62 protein, and suppressed hepatocyte senescence. In addition, PTUPB enhanced hepatocyte autophagy by inhibiting the PI3K/AKT/mTOR pathway through Sirt1, contributing to the suppression of senescence. PTUPB inhibits the PI3K/AKT/mTOR pathway through Sirt1, improves autophagy, slows down the senescence of hepatocytes, and alleviates NAFLD.

1 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
CZChen-Yu Zhang
Chen-Yu Zhang
XGXin-Xin Guan
Xin-Xin Guan
ZSZhuo-Hui Song
Zhuo-Hui Song
HJHui-Ling Jiang
Hui-Ling Jiang
YLYu-Biao Liu
Yu-Biao Liu
YZYong Zhou
Yong Zhou
Background. Arachidonic acid (ARA) metabolites are involved in the pathogenesis of epithelial‐mesenchymal transformation (EMT). However, the role of ARA metabolism in the progression of EMT during pulmonary fibrosis (PF) has not been fully elucidated. The purpose of this study was to investigate the role of cytochrome P450 oxidase (CYP)/soluble epoxide hydrolase (sEH) and cyclooxygenase‐2 (COX‐2) metabolic disorders of ARA in EMT during PF. Methods. A signal intratracheal injection of bleomycin (BLM) was given to induce PF in C57BL/6 J mice. A COX‐2/sEH dual inhibitor PTUPB was used to establish the function of CYPs/COX‐2 dysregulation to EMT in PF mice. In vitro experiments, murine alveolar epithelial cells (MLE12) and human alveolar epithelial cells (A549) were used to explore the roles and mechanisms of PTUPB on transforming growth factor (TGF)‐β1‐induced EMT. Results. PTUPB treatment reversed the increase of mesenchymal marker molecule α‐smooth muscle actin (α‐SMA) and the loss of epithelial marker molecule E‐cadherin in lung tissue of PF mice. In vitro, COX‐2 and sEH protein levels were increased in TGF‐β1‐treated alveolar epithelial cells (AECs). PTUPB decreased the expression of α‐SMA and restored the expression of E‐cadherin in TGF‐β1‐treated AECs, accompanied by reduced migration and collagen synthesis. Moreover, PTUPB attenuated TGF‐β1‐Smad2/3 pathway activation in AECs via Nrf2 antioxidant cascade. Conclusion. PTUPB inhibits EMT in AECs via Nrf2‐mediated inhibition of the TGF‐β1‐Smad2/3 pathway, which holds great promise for the clinical treatment of PF.

14 May 2026 in International Immunopharmacology
Verified
Journal Article
Closed access
AWAn-Mei Wang
An-Mei Wang
ZYZhen Yu
Zhen Yu
RGRen Guo
Ren Guo
MTMi-Mi Tang
Mi-Mi Tang
LLLi-Ying Liang
Li-Ying Liang
DLDai Li
Dai Li

9 July 2026 in European Journal of Pharmacology
Verified
Journal Article
Closed access
HXHai-Yan Xiao
Hai-Yan Xiao
MJMing-Hao Jiang
Ming-Hao Jiang
WZWen-Jing Zhong
Wen-Jing Zhong
JDJia-Xi Duan
Jia-Xi Duan
NYNan-Shi-Yu Yang
Nan-Shi-Yu Yang
DLDai Li
Dai Li